Virus Prevention Claims For RhinoSystems’ Naväge Flushed In Nasal Irrigation Advertising Review

 
• By Malcolm Spicer

During NAD review, RhinoSystems stated it previously pulled some COVID-19 prevention claims NeilMed challenged and pulled remaining ads after review began. Both RhinoSystems, which markets Naväge brand, and NeilMed, offering a namesake brand, were warned in 2021 by FTC about COVID-19 ad claims.

• Source: Shutterstock

An advertising dispute between two US nasal irrigation device firms was flushed out in a review by an industry self-regulation group finding one made unsupported virus prevention claims in TV and radio commercials.

BBB National Program Inc.’s National Advertising Division reports that during its review, the firm, RhinoSystems Inc., stated that it had already pulled some COVID-19 prevention claims challenged by NeilMed Pharmaceuticals...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Policy & Regulation